AlphaCor™ cases -: Comparative outcomes

被引:35
作者
Hicks, CR
Crawford, GJ
Tan, DT
Snibson, GR
Sutton, GL
Downie, N
Gondhowiardjo, TD
Lam, DSC
Werner, L
Apple, D
Constable, IJ
机构
[1] Lions Eye Inst, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia
[3] Singapore Natl Eye Ctr, Singapore, Singapore
[4] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia
[5] Sydney Eye Hosp, Sydney, NSW, Australia
[6] Launceston Gen Hosp, Launceston, Tas, Australia
[7] Jakarta Eye Ctr, Jakarta, Indonesia
[8] Hong Kong Eye Hosp, Hong Kong, Hong Kong, Peoples R China
[9] Med Univ S Carolina, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA
关键词
artificial cornea; outcomes and complications; keratoprosthesis;
D O I
10.1097/00003226-200310000-00001
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: To describe clinical outcomes after a novel type of corneal surgery, implantation of an artificial cornea, AlphaCorr(TM), and to evaluate outcomes in comparison with alternative keratoprostheses and high-risk grafts. Methods: Case reports and data from a noncontrolled clinical trial and a literature review. Results: The probability of AlphaCor retention to 1 year is 80%. Postoperative best corrected visual acuity ranges from Perception Light to 20/30. The most significant complications are stromal melts and optic depositions, for both of which the main risk factors have been identified. Complications can be managed without loss of the eye. Conclusion: Results from the clinical trial period have helped to determine the indications and risk factors for AlphaCor surgery and to refine surgical techniques. Continued monitoring of outcomes as the series increases will allow a more accurate determination of comparative outcomes. The series provides preliminary evidence that AlphaCor may have a lower incidence of complications than traditional keratoprostheses and may prove to be preferable to a donor graft in high-risk cases.
引用
收藏
页码:583 / 590
页数:8
相关论文
共 16 条
[1]
AQUAVELLA JV, 1982, OPHTHALMOLOGY, V89, P655
[2]
The Chirila Keratoprosthesis: Phase I human clinical trial [J].
Crawford, GJ ;
Hicks, CR ;
Lou, X ;
Vijayasekaran, S ;
Tan, D ;
Mulholland, B ;
Chirila, TV ;
Constable, IJ .
OPHTHALMOLOGY, 2002, 109 (05) :883-889
[3]
SOME FACTORS INFLUENCING OUTCOME AFTER KERATOPROSTHESIS SURGERY [J].
DOHLMAN, CH ;
DOANE, MG .
CORNEA, 1994, 13 (03) :214-218
[4]
Development and clinical assessment of an artificial cornea [J].
Hicks, C ;
Crawford, G ;
Chirila, T ;
Wiffen, S ;
Vijayasekaran, S ;
Lou, X ;
Fitton, J ;
Maley, M ;
Clayton, A ;
Dalton, P ;
Platten, S ;
Ziegelaar, B ;
Hong, Y ;
Russo, A ;
Constable, I .
PROGRESS IN RETINAL AND EYE RESEARCH, 2000, 19 (02) :149-170
[5]
Melting after keratoprosthesis implantation: The effects of medroxyprogesterone [J].
Hicks, CR ;
Crawford, GJ .
CORNEA, 2003, 22 (06) :497-500
[6]
Corneal replacement using a synthetic hydrogel cornea, AlphaCor™ device, preliminary outcomes and complications [J].
Hicks, CR ;
Crawford, GJ ;
Lou, X ;
Tan, DT ;
Snibson, GR ;
Sutton, G ;
Downie, N ;
Werner, L ;
Chirila, TV ;
Constable, IJ .
EYE, 2003, 17 (03) :385-392
[7]
Outcomes of implantation of an artificial cornea, AlphaCor - Effects of prior ocular herpes simplex infection [J].
Hicks, CR ;
Crawford, GJ ;
Tan, DT ;
Snibson, GR ;
Sutton, GL ;
Gondhowiardjo, TD ;
Lam, DSC ;
Downie, N .
CORNEA, 2002, 21 (07) :685-690
[8]
Keratoprostheses: Advancing toward a true artificial cornea [J].
Hicks, CR ;
Fitton, JH ;
Chirila, TV ;
Crawford, GJ ;
Constable, IJ .
SURVEY OF OPHTHALMOLOGY, 1997, 42 (02) :175-189
[9]
HITZL W, IN PRESS J THEORET M
[10]
UNUSUAL DEPOSITS IN THE SUPERFICIAL CORNEAL STROMA FOLLOWING COMBINED USE OF TOPICAL CORTICOSTEROID AND BETA-BLOCKING MEDICATION [J].
HUIGE, WMM ;
BEEKHUIS, WH ;
RIJNEVELD, WJ ;
SCHRAGE, N ;
REMEIJER, L .
DOCUMENTA OPHTHALMOLOGICA, 1991, 78 (3-4) :169-175